Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progression
-
Published:2021-04-07
Issue:1
Volume:125
Page:78-84
-
ISSN:0007-0920
-
Container-title:British Journal of Cancer
-
language:en
-
Short-container-title:Br J Cancer
Author:
Emond Jean-Philippe, Lacombe LouisORCID, Caron Patrick, Turcotte Véronique, Simonyan David, Aprikian Armen, Saad Fred, Carmel Michel, Chevalier Simone, Guillemette ChantalORCID, Lévesque EricORCID
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Reference65 articles.
1. Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M. et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J. Clin. 69, 363–385 (2019). 2. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. & Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018). 3. Pishgar, F., Ebrahimi, H., Saeedi Moghaddam, S., Fitzmaurice, C. & Amini, E. Global, regional and national burden of prostate cancer, 1990 to 2015: results from the Global Burden of Disease Study 2015. J. Urol. 199, 1224–1232 (2018). 4. Lorent, M., Maalmi, H., Tessier, P., Supiot, S., Dantan, E. & Foucher, Y. Meta-analysis of predictive models to assess the clinical validity and utility for patient-centered medical decision making: application to the cancer of the prostate risk assessment (CAPRA). BMC Med. Inf. Decis. Mak. 19, 2 (2019). 5. Fraser, M., Sabelnykova, V. Y., Yamaguchi, T. N., Heisler, L. E., Livingstone, J., Huang, V. et al. Genomic hallmarks of localized, non-indolent prostate cancer. Nature 541, 359–364 (2017).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|